The Claim
Plasma p-tau217 levels show no significant correlation with cognitive performance as measured by the Mini-Mental State Examination in individuals with Alzheimer’s dementia or mild cognitive impairment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with Alzheimer’s dementia or mild cognitive impairment, the amount of p-tau217 in the blood does not change with how well they perform on memory and thinking tests.
See the scientific wording
Plasma p-tau217 levels do not significantly correlate with cognitive performance as measured by the Mini-Mental State Examination in individuals with Alzheimer’s dementia or mild cognitive impairment, suggesting that p-tau217 reflects underlying pathology rather than current symptom severity.
Tau proteins clump into tangles inside brain cells as Alzheimer’s progresses, and these tangles release a specific form of tau into the blood. This form shows up in plasma regardless of how well the person is thinking or remembering, because the tangles form long before brain circuits stop working properly.
What the research says
1 studyThe study shows that a blood marker called p-tau217 can detect Alzheimer’s disease even in its early stages, but it doesn’t say whether higher levels mean someone has worse memory problems. So it doesn’t prove the claim, but it also doesn’t contradict it — it just doesn’t test that part.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.